Industry: Health Care – Industrial Specialties
Stock Symbol: AVR – NASDAQ
Animal Usage: Animal Testing, Meat/Dairy/Eggs
Anteris Technologies Global Corp. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their medical devices on animals to assess a product’s safety profile and utilize animal-derived tissues.
Supporting Evidence:
The company confirms in corporate disclosures that their products contain animal tissues and that they utilize animal subjects for product testing.
“The DurAVR® valve leaflets are bovine pericardium tissue that has been treated with Anteris Technologies’ patented anti-calcification platform, ADAPT®.” Read the article for more details
“Based on these results, Anteris plans to start a larger animal study in Australia during 2021 implanting the conduit into the CABG position.” Read the article for more details
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. Anteris Technologies Global Corp. is based in Toowong, Australia.
Company Website: https://anteristech.com/home.html